TLE4 and hepatocellular carcinoma: TLE4 shows significantly reduced expression (p = 1.7 × 10−2; FDR = 0.20; Wilcoxon rank-sum test) in three Liver-HCC tumors with TLE4 promoter mutations (Fig. 3b; Supplementary Fig. 10).